Amplitude Ventures is a full-stack Canadian venture capital firm based in Montreal that creates, builds, and grows precision medicine companies at the intersection of biology and AI. The firm invests across therapeutics, medical technologies, and healthcare IT from ideation through patient care.
77% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $56.1M (across 22 rounds with reported amounts).
Portfolio
19
Fund Size
—
Top Stage
Series B
Last 12 Mo
2
Team
Dion Madsen
Managing Partner
Allison Gaw
Partner
Matthew Rosenberger
Partner, CFO
Riccardo Cardilli
Finance Director
Juliana Muñoz Escobar
Associate
Colton Strong
Analyst
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
26 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Congruence Therapeutics | Series B | $39.5M | Mar 2026 |
 Mediar | Series B | $76M | Jan 2026 |
| Congruence Therapeutics | Unknown | $32M | Sep 2025 |
 FLUID BIOMED | Series A | $27M | Dec 2024 |
 Evommune | Series C | $115M | Oct 2024 |
| EEVOMMUNE INC. | Series C | $115M | Oct 2024 |
 Ability Biologics | Seed | $18M | Jun 2024 |
 Nomic Bio | Series B | $42M | Jan 2024 |
| FFluid Biomed Inc | Series A | $27M | Jan 2024 |
| NNomic Bio | Series B | $42M | Jan 2024 |
| Evommune | Series B | $50M | Apr 2023 |
| Congruence Therapeutics | Series A | $65M | Mar 2023 |
 Abdera Therapeutics | Series B | $110M | Jan 2023 |
 Drugbank | Seed | — | Apr 2022 |
 Celsius Therapeutics | Series A | $63M | Mar 2022 |
| Celsius Therapeutics | Series B | $83M | Mar 2022 |
| Congruence Therapeutics | Series A | $50M | Feb 2022 |
 Notch Therapeutics | Series A | $85M | Feb 2021 |
| Abdera Therapeutics | Series A | $32.5M | Jan 2021 |
| MMediar Therapeutics | Series B | $76M | — |
 Gandeeva Therapeutics | Series A | $40M | — |
 Radiant Biotherapeutics | Series A | — | — |
| Radiant Biotherapeutics | Seed | — | — |
 Tentarix Biotherapeutics | Series B | $35M | — |
 Reverb Therapeutics | Seed | $12M | — |
Page 1 of 2
Top Co-Investors
Alexandria Venture Investments5 shared
Longwood Fund4 shared
Andera Partners3 shared
EQT Life Sciences3 shared
SymBiosis3 shared
Investissement Québec3 shared
Casdin Capital3 shared
Illumina Ventures3 shared
OrbiMed3 shared
Versant Ventures3 shared
Amgen Ventures3 shared
Lux Capital3 shared
B Capital2 shared
Beiersdorf Venture Capital2 shared
Sectoral Asset Management2 shared
Pivotal Life Sciences2 shared
RA Capital Management2 shared
Samsara BioCapital2 shared
Fonds de solidarité FTQ2 shared
Last updated: 8 September 2026